2Q17 was mainly driven by larger rental areas in the new store and gain on sale of current investment to expand business purpose. The ratio of other income in 2Q17 increased to 4.84% compared with 3.10

a 3 to 6 month time lag due to the ordering lead time. Plant expansion will depend on the current building utilisation and lead time to construct new plant or expand in an existing plant. Source of

and increase FN brand equity in a long run. For the proportion of other income to total revenue, the Company was able to maintain proportionate compared to previous period. The Company targets to expand

% of the total shares. However, ACSI would like to increase capital registered from IDR 100,200 million to IDR 200,400 million in order to expand its business in Indonesia. Existing shareholders

well, the Company also intends to expand our business to CLMV countries (Cambodia, Lao PDR, Myanmar, Vietnam), which obtain an interesting direction of business growth. In the first quarter of , the

order to encourage new customers and retain our existing customer base. The Company is still working on plan and can achieve goals Operating results in 2018, the company had a total of 130,053 Boonterm

program, to increase the usage frequency on existing customers and encourage new customers For the operating result in 1Q2020, the total transaction amount was Bt9,630mn, decreasing 6.8% YoY. However, the

increase production capability and shorten lead time for sales to customers in the US and nearby countries 2. To expand distribution network in the American continent and create opportunity for more income

prior period which mainly increased from the existing customers expanding the services. Moreover, when compared to the same period of prior year, it was increased by THB 10.8 million or 8.6%. For the six

period at the previous year. The Company plans to improve and increase the sales team to increase sales efficiency in distributor of medical devices and equipment business, expanding the existing customer